The One MSL Podcast: Medical Science Liaison Excellence One MSL

Medical Affairs strategy is increasingly reliant on the important work of Field Medical / MSL Teams to provide the voice and opinions of the KOL and HCP, through insight collection, to drive achievement of Medical Strategic Plans.With challenges persisting around gaining access to KOLs, how can you make every interaction count, ensuring optimum collection and distribution of key information?In this session Field Medical Experts Carol Heggie & Helen Kane unlock the keys to success in Mastering Strategic Insight Collection by sharing optimal ways to:• Use your KOL profiling and Medical Plan to “power-up” your discussions by taking a Patient-Centric approach• Employ Active Listening to ask better questions that get you to “why” and to understanding your KOL’s beliefs and mindset• Analyze what you learn and know how to develop your insights further in future meetings• Harness curiosity as a superpower for collecting impactful information and increase KOL collaboration• Recognize the relevance of your insight in the achievement of Medical StrategyWe hope you enjoy the episode!One MSL Community Team

https://www.onemsl.com/

To mark the launch of the One MSL Global Survey 2024, we took the opportunity to reflect on survey findings gathered in 2023 and looked ahead to anticipated and surprising industry trends just around the corner.

Episode hosts: Helen Kane, One MSL CEO, and Carol Heggie, One MSL Medical Excellence Lead.



Complete the 2024 One MSL Survey here by heading to the front page of our website: https://www.onemsl.com/

You can also download the 2023 reports here!

One MSL & SPARK Evidence are pleased to present ‘Real World Evidence 101’.Join Helen Kane, One MSL CEO, alongside Samantha Oliver & Georgie Nock, Directors & Founders of SPARK Evidence as they explore Real World Evidence in the context of Medical Affairs amongst an evolving industry. This episode serves as an introduction to the subject of Real World Evidence and will be of great value to biopharma industry colleagues.We hope you enjoy the episode!Many thanks,One MSL Community Team




https://www.onemsl.com/

In this episode Helen and a panel of industry experts explore how the MSL role is changing and what the modern MSL requires to succeed in-role.



https://www.onemsl.com/

Our mission at One MSL is to support the global MSL community in the achievement of field medical excellence.Helen Kane, One MSL CEO and industry colleagues collaborated to recognise the evolution of the MSL role. Helen was joined by Vic Ho, Medical Excellence Consultant; Valentina Svetic, Head of MSLs, Oncology, Daiichi-Sankyo UK; and Jodi Tainton, Senior Manager, Field Medical Excellence, Pfizer.Their conversation proved lively as they reflected on achievements to-date and the exciting prospect of what is yet to come. What are the greatest MSL achievements from your perspective? Let us know on the One MSL LinkedIn page.

We hope you enjoy the recording!One MSL Community Team


https://www.onemsl.com/

Findings from our 2022 Global Survey show that MSLs are engaging externally as early as Phase 1 of the clinical development programme. This finding led to a conversation between Helen Kane, Paul Reynolds, Sanda Rocak & Esther Nzenza, in which they started to explore what MSLs and the wider team needed to know and do to be effective in early life-cycle engagement. It is evident that there is significant scope to collaborate earlier across medical affairs, marketing, market access and clinical development to fully unleash the power of all four. From that single conversation grew the idea for a webinar where they would meet to discuss a number of relevant questions around the opportunities and challenges which can exist for any organisation.
We hope that you enjoy the episode! 

One MSL Community Team



https://www.onemsl.com/